India CRO Veeda Buys International Oncology Network To Grow Global Oncology Research
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Start-up CRO Veeda Clinical Research has acquired U.S.-based clinical research outfit International Oncology Network in a deal estimated at $10 million. With the acquisition, Veeda hopes to gain a toehold in the expanding business of clinical research in oncology
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)